期刊
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
卷 65, 期 3, 页码 334-343出版社
WILEY
DOI: 10.1111/j.1600-0897.2010.00949.x
关键词
Antimicrobials; female reproductive tract; HIV; selective estrogen response modifier
资金
- National Institutes of Health [AI-51877, AI-13541, AI-071761, AI084121]
- Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative
P>The studies presented in this review explore three distinct areas with potential for inhibiting HIV infection in women. Based on emerging information from the physiology, endocrinology and immunology of the female reproductive tract (FRT), we propose unique 'works in progress' for protecting women from HIV. Various aspects of FRT immunity are suppressed by estradiol during the menstrual cycle, making women more susceptible to HIV infection. By engineering commensal Lactobacillus to secrete the anti-HIV molecule Elafin as estradiol levels increase, women could be protected from HIV infection. Selective estrogen response modifiers enhance barrier integrity and enhance secretion of protective anti-HIV molecules. Finally, understanding the interactions and regulation of FRT endogenous antimicrobials, proteases, antiproteases, etc., all of which are under hormonal control, will open new avenues to therapeutic manipulation of the FRT mucosal microenvironment. By seeking new alternatives to preventing HIV infection in women, we may finally disrupt the HIV pandemic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据